# A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis

> **NCT04179500** · PHASE2 · COMPLETED · sponsor: **Global Alliance for TB Drug Development** · enrollment: 26 (actual)

## Conditions studied

- Tuberculosis, Pulmonary
- Tuberculosis, Multidrug-Resistant
- Tuberculosis, MDR
- Tuberculosis
- Drug-Resistant Tuberculosis

## Interventions

- **DRUG:** Pretomanid
- **DRUG:** Bedaquiline
- **DRUG:** moxifloxacin
- **DRUG:** pyrazinamide

## Key facts

- **NCT ID:** NCT04179500
- **Lead sponsor:** Global Alliance for TB Drug Development
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-16
- **Primary completion:** 2023-06-19
- **Final completion:** 2024-07-17
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2025-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04179500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04179500, "A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT04179500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*